
- Volume 0 0
E-Prescribing Available for Gold Standard Customers
Gold Standard, a developer of drug information databases, software, and clinical information solutions, has been recognized as a SureScripts Certified Solutions Provider. The recognition allows users of Gold Standard's eMPOWERx patient care system to electronically access and conduct 2-way communications with US pharmacies connected to the SureScripts network, including transmitting new prescriptions and authorizing refills.
Gold Standard's eMPOWERx application integrates preferred drug lists and the company's clinical pharmacology drug information and interaction screening tools in real-time, patient-specific medication histories. With Gold Standard's electronic prescribing (e-prescribing) module connected to SureScripts Messenger Services, providers electronically transmit new prescriptions and expedite renewals.
"We believe that improving the flow of information between the physician and pharmacist represents a tremendous opportunity to positively impact patient care," said Russ Thomas, chief executive officer of Gold Standard.
Experts believe that e-prescribing will help transform the medication process. A recent House subcommittee heard testimony that e-prescribing could improve patient care, boost efficiency, and save as much as $27 billion in health care costs because of fewer medication errors and reduced duplication.
Articles in this issue
almost 21 years ago
Geriatric Pharmacologyalmost 21 years ago
Management of Bacterial Rhinosinusitisalmost 21 years ago
Early RA Treatment Proves Beneficialalmost 21 years ago
Topical Creams Work Temporarilyalmost 21 years ago
Mental Anguish Is Common with Arthritisalmost 21 years ago
Overview of Astrocytomas?The Pharmacist's Perspectivealmost 21 years ago
Scanner Detects Hand Arthritisalmost 21 years ago
OA: All in the Familyalmost 21 years ago
Sheriff Sues Board for Searching His Rx Records Without a Warrantalmost 21 years ago
Restricting the Sale of Cold MedicationsNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.